|1.||Bongiorno-Borbone, Lucilla: 1 article (07/2015)|
|2.||Giacobbe, Arianna: 1 article (07/2015)|
|3.||Compagnone, Mirco: 1 article (07/2015)|
|4.||Melino, Gerry: 1 article (07/2015)|
|5.||Peschiaroli, Angelo: 1 article (07/2015)|
|6.||Eramo, Adriana: 1 article (07/2015)|
|7.||De Maria, Ruggero: 1 article (07/2015)|
|8.||Yang, Joy C: 1 article (09/2014)|
|9.||Evans, Christopher P: 1 article (09/2014)|
|10.||Farrow, Jason M: 1 article (09/2014)|
|1.||Panic Disorder (Panic Attack)
|2.||Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/01/2012 - "The aim of this study was to explore the possible relationship between plasma clomipramine and its major metabolite (N-desmethylclomipramine) levels and related parameters, and clinical features in patients with obsessive-compulsive disorder (OCD). "
01/01/1990 - "The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder."
01/01/1980 - "Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis."
01/01/1980 - "The relationship between plasma levels of clomipramine and desmethylclomipramine and clinical response was studied in a group of patients with obsessive-compulsive neurosis. "
08/01/1979 - "The cerebrospinal fluid (CSF) and plasma levels of demethylchlorimipramine (DMCI) were determined during treatment of depression or obsessive-compulsive disorders with chlorimipramine. "
09/01/2014 - "Indeed, preclinical studies have shown that the pharmacological inhibition of autophagy (with agents including chloroquine, hydroxychloroquine, metformin, and desmethylclomipramine) can enhance the cell-killing effect of cancer therapeutics, and a number of these agents are currently under investigation in clinical trials. "
|4.||Myoclonus (Nocturnal Myoclonus)
|5.||Lung Neoplasms (Lung Cancer)